Rhodiola Rosea
Adaptogenic root extract with moderate randomized-trial evidence for stress resilience, fatigue resistance, and physical and cognitive performance under load. Recent 2025–2026 RCTs show gains in strength, fatigue-resistant endurance and executive function, alongside modest reductions in perceived stress and mild-depression symptoms.
Mechanism of Action
Acts on the hypothalamic–pituitary–adrenal (HPA) axis to blunt stress-induced cortisol release and modulates stress-activated protein kinase (JNK) signaling. The active rosavins and salidroside influence monoamine neurotransmission (serotonin, dopamine, norepinephrine), support cellular energy metabolism (AMPK and mitochondrial ATP production), and may attenuate fatigue signaling during physical and mental load.
Latest Research
Reviewed Oct 3, 2026
Rhodiola rosea is an adaptogenic root standardized to rosavins and salidroside, studied for stress resilience, fatigue, and performance under load. A 2025 systematic review of 24 adaptogen randomized controlled trials (19 on Rhodiola; Annals of Agricultural and Environmental Medicine) concluded that standardized extracts at roughly 120–1000 mg/day for 3–16 weeks produce multi-dimensional adaptogenic effects — lower stress and anxiety, improved mood and sleep, and better cognition — mediated through HPA-axis, neurotransmitter and hormonal pathways, while cautioning that most trials are short and small. The most informative recent trial is a 2025 randomized, double-blind, placebo-controlled crossover in 27 resistance-trained adults (Koozehchian et al., Nutrients): versus a no-supplement control, short-term Rhodiola raised leg-press one-rep-max by +35.7 kg at the low dose and +47.7 kg at the high dose (both p < 0.001), increased bench-press 1RM (+5.59 kg, p = 0.003) and repetitions to failure, and improved executive function on the Stroop test across all subtests (p < 0.05), with little effect on anaerobic cycling power or perceived exertion. A 2026 randomized controlled trial in competitive footballers (Nutrients) found four weeks of Rhodiola improved high-intensity intermittent running (Yo-Yo IR2, p = 0.012), lowered post-exercise blood lactate, and sharpened reaction time and decision accuracy under fatigue — the authors framed the benefit as better performance maintenance under fatigue rather than higher peak capacity. A 2025 meta-analysis of options for mild depression (Neuropsychopharmacology Reports) reported that Rhodiola significantly improved depressive symptoms versus placebo. Findings are not uniform: a 2025 mental-fatigue crossover trial found Rhodiola’s effects were mainly on physical performance, with only trivial-to-small changes in cognitive or perceived-fatigue measures, so individual responses vary. Rhodiola is generally well tolerated; insomnia or vivid dreams can occur if taken late, and irritability at higher doses. Because it is serotonergic, it may add to the effects of SSRIs and similar medicines and is best avoided in bipolar disorder or combined with such drugs without physician oversight, and used cautiously in pregnancy. This is educational information, not a treatment for any condition — discuss supplementation with your physician.
Latest Evidence · Randomized Crossover RCT (2025)
Rhodiola Rosea: Dose-Dependent Gain in Lower-Body Strength
Change in leg-press one-rep-max versus a no-supplement control after short-term Rhodiola rosea in 27 resistance-trained adults (randomized, double-blind, placebo-controlled crossover); both doses p < 0.001. Bench-press 1RM also rose with the low dose (+5.59 kg, p = 0.003) and executive function (Stroop) improved across all subtests, while anaerobic cycling power was largely unchanged. Source: Koozehchian et al., Nutrients, 2025.
Latest research
- Koozehchian MS, et al. Dose-Response Effects of Short-Term Rhodiola rosea (Golden Root Extract) Supplementation on Anaerobic Exercise Performance and Cognitive Function in Resistance-Trained Athletes: A Randomized, Crossover, Double-Blind, Placebo-Controlled Study. Nutrients, 2025.
- Dou Y, et al. Effects of Rhodiola rosea on Physical and Decision-Making Performance in Football Players: A Randomised Controlled Trial. Nutrients, 2026.
- Łuszczak J, Kocki J. Clinical evidence for the adaptogenic effects of Rhodiola rosea and Withania somnifera: a systematic review. Annals of Agricultural and Environmental Medicine, 2025.
- Urata M, et al. Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta-Analysis. Neuropsychopharmacology Reports, 2025.
- Marcos-Frutos D, et al. The Impact of Rhodiola Rosea Extract on Strength Performance Under Resting and Mental Fatigue Conditions: A Randomized, Triple-Blinded, Placebo-Controlled, Crossover Trial. Nutrients, 2025.
- Lara PM, et al. Can Rhodiola rosea supplementation mitigate digital eye strain? A triple-blinded placebo-controlled study. Ophthalmic & Physiological Optics, 2025.
Related on Peak Human
Dosing Protocol
400mg (3% rosavins, 1% salidroside)mg
Standard starting dose based on research
Therapeutic Range
200
Minimum
600
Maximum
Morning on empty stomach, cycle 5 days on/2 off
Dosages are general guidelines. Individual requirements vary based on body weight, health status, and specific goals. Start with lower doses and adjust based on response.
Benefits
Primary Benefits
- Fatigue reduction
- Stress resilience
- Cognitive performance
- Exercise endurance
Secondary Benefits
Safety Information
Contraindications
Do not use if any of the following apply:
- •Bipolar disorder
- •SSRIs (additive serotonin)
Potential Side Effects
Some users may experience:
This is not a complete list of interactions or side effects. Individual responses vary. Always start with the lowest effective dose and monitor your response. Report any adverse effects to your healthcare provider.
Quality Markers
Look for these specific quality indicators when sourcing this compound:
- SHR-5 extract standardized
- 3% rosavins / 1% salidroside
- Root extract only
Trusted Certifications
Note: Supplement quality varies dramatically between brands. Cheap supplements often contain fillers, incorrect doses, or contaminants. Investing in quality products from reputable manufacturers is essential for safety and efficacy.
Evidence Profile
Evidence Score
7/10
Moderate Evidence
Some clinical trials with positive results, emerging research
Evidence Scale
8-10
Strong
5-7
Moderate
1-4
Emerging
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
